SAS Output

23-FEB-2019 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1400-SCCA,Adv, Biomarker Master 1 N 1 Specimen Submission   1864 341 102 29 4 0 07/08/2014 455 206
            1864 341 102 29 4 0      
 
    2 Y 17 S1400G   62 18 0 0 0 0      
        2 S1400A   160 0 0 0 0 0 07/08/2014    
        21 S1400F   141 112 59 22 4 1      
        25 S1400K   50 49 5 0 0 0      
        3 S1400B   53 0 0 0 0 0      
        30 S1900A   4 4 4 4 4 1      
        4 S1400C   88 0 0 0 0 0      
        5 S1400D   92 0 0 0 0 0      
        6 S1400E   16 0 0 0 0 0      
        7 S1400I   700 19 0 0 0 0      
            1366 202 68 26 8 2      
 
    3 P 10 S1400I   13 3 0 0 0 0      
        18 S1400G   10 1 0 0 0 0      
        22 S1400F   26 20 3 1 1 1      
        32 S1900A   2 2 2 2 2 0      
        8 S1400B   1 0 0 0 0 0 07/08/2014    
            52 26 5 3 3 1      
 
    4 P 23 S1400F   3 2 0 0 0 0 07/08/2014    
            3 2 0 0 0 0      
 
  S1400F-Non-Match: MEDI4736 + Tremelimumab 1 Y 1 MEDI4736 + Tremelimumab 132 56 44 27 10 2 1 11/30/2017 455 206
            56 44 27 10 2 1      
 
  S1619-Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 1 Y 1 Chemotherapy + Atezolizumab 28 10 10 6 4 2 0 07/16/2018 74 24
            10 10 6 4 2 0      
 
    2 Y 2 Surgery 28 3 3 3 2 0 0 07/16/2018    
            3 3 3 2 0 0      
 
    3 Y 3 Maintenance 28 1 1 1 1 0 0 07/16/2018    
            1 1 1 1 0 0      
 
  LUNGMAP-NSCLC, Adv, Master 0 Y 0 ctDNA Specimen Submission   5 5 5 5 5 3 02/06/2019 204 91
            5 5 5 5 5 3      
 
    1 Y 1 Tissue Submission   20 20 20 20 20 8 02/06/2019    
            20 20 20 20 20 8      
 
Yes A081105-ALCHEMIST1, EGFR mut, Erlotinib 1 E Total Registrations   48 15 8 4 1 0 04/01/2015 499 253
            48 15 8 4 1 0      
 
  A151216-ALCHEMIST0 - screening 1 E Total Registrations   664 215 82 42 13 3 12/16/2014 493 253
            664 215 82 42 13 3      
 
  C30610-SCLC, Thoracic RT 1 E Total Registrations   56 1 0 0 0 0 05/14/2008 167 86
            56 1 0 0 0 0      
 
  E4512-ALCHEMIST2, ALK mut, Crizotinib 1 E Total Registrations   12 5 3 2 0 0 02/29/2016 380 218
            12 5 3 2 0 0      
 
  NRGCC003-SCLC, PCI or HA-PCI 1 E Total Registrations   4 0 0 0 0 0 10/20/2016 258 125
            4 0 0 0 0 0      
 
    2 E Total Registrations   4 0 0 0 0 0 10/20/2016    
            4 0 0 0 0 0      
 
No A151216-ALCHEMIST0 - screening 0 E Total Registrations   673 216 85 42 13 3 12/16/2014 493 253
            673 216 85 42 13 3      
 
  EA5142-ALCHEMIST3, Non-match, Nivolumab 1 E Total Registrations   93 57 27 15 7 0 08/03/2016 469 250
            93 57 27 15 7 0      
 

23-FEB-2019 6:10

LUNG Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1701 Thymic Adv, Carbo/Pac/Ram vs. Carbo/Pac 1 Randomization 09-Aug-18
S1900A LOH and/or BRCA: Rucaparib 1 Registration 28-Jan-19
LUNGMAP NSCLC, Adv, Master 2 Sub-study Assignment 28-Jan-19
  3 Sub-study Assignment II 28-Jan-19
  4 Sub-study Assignment III 28-Jan-19
  5 Sub-study Assignment IV 28-Jan-19